- Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Eleventh Edition. CLSI document M07-A11. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2018.
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-ninth Edition. CLSI supplement M100-S29. Wayne, PA: Clinical Laboratory Standards Institute; 2019.
- CLSI. Performance Standards for Antimicrobial Disk Diffusion Susceptibility Tests; Thirteenth Edition. CLSI Document M02-A13. Wayne, PA: Clinical Laboratory Standards Institute; 2018.
ALTABAX is supplied in 15-gram and 30-gram tubes.
NDC 16110-518-15 (15-gram tube)
NDC 16110-518-30 (30-gram tube)
Store at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F).
Patients using ALTABAX and/or their guardians should receive the following information and instructions:
- Use ALTABAX as directed by the healthcare practitioner. As with any topical medication, patients and caregivers should wash their hands after application if the hands are not the area for treatment.
- ALTABAX is for external use only. Do not swallow ALTABAX or use it in the eyes, on the mouth or lips, inside the nose, or inside the female genital area.
- The treated area may be covered by a sterile bandage or gauze dressing, if desired. This may also be helpful for infants and young children who accidentally touch or lick the lesion site. A bandage will protect the treated area and avoid accidental transfer of ointment to the eyes or other areas.
- Use the medication for the full time recommended by the healthcare practitioner, even though symptoms may have improved.
- Notify the healthcare practitioner if there is no improvement in symptoms within 3 to 4 days after starting use of ALTABAX.
- ALTABAX may cause reactions at the site of application of the ointment. Inform the healthcare practitioner if the area of application worsens in irritation, redness, itching, burning, swelling, blistering, or oozing.
ALTABAX is a registered trademark of Almirall, S.A.
Manufactured for: Almirall, LLC, Malvern, PA 19355 © 2019 Almirall, LLC. All rights reserved.
PRINCIPAL DISPLAY PANEL — NDC: 16110-518-15 — 15 g Tube Label
|ALTABAX retapamulin ointment|
|Labeler — Almirall, LLC (605425912)|
Revised: 06/2023 Almirall, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.